Alcon, RxSight to develop light-adjustable presbyopia-correcting IOL

Alcon and RxSight announced a nonexclusive collaboration to develop a light-adjustable presbyopia-correcting IOL, according to a press release. “This collaboration will enable surgeons to fine-tune visual outcomes for their cataract patients who choose a PCIOL, which is not an available option today,” Ron Kurtz, MD, president and CEO of RxSight, told Healio.